首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.
【24h】

Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.

机译:维生素K1(叶醌)和维生素D3加钙对老年女性骨骼健康的两年随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

Dietary supplementation with vitamin K(1), with vitamin D(3) and calcium or their combination, was examined in healthy older women during a 2-year, double-blind, placebo-controlled trial. Combined vitamin K with vitamin D plus calcium was associated with a modest but significant increase in BMC at the ultradistal radius but not at other sites in the hip or radius. INTRODUCTION: The putative beneficial role of high dietary vitamin K(1) (phylloquinone) on BMD and the possibility of interactive benefits with vitamin D were studied in a 2-year double-blind, placebo-controlled trial in healthy Scottish women > or =60 years of age. MATERIALS AND METHODS: Healthy, nonosteoporotic women (n = 244) were randomized to receive either (1) placebo, (2) 200 microg/day vitamin K(1), (3) 10 microg (400 IU) vitamin D(3) plus 1000 mg calcium/day, or (4) combined vitamins K(1) and D(3) plus calcium. Baseline and 6-month measurements included DXA bone mineral scans of the hip and wrist, markers of bone turnover, and vitamin status. Supplementation effects were tested using multivariate general linear modeling, with full adjustment for baseline and potential confounding variables. RESULTS: Significant bone mineral loss was seen only at the mid-distal radius but with no significant difference between groups. However, women who took combined vitamin K and vitamin D plus calcium showed a significant and sustained increase in both BMD and BMC at the site of the ultradistal radius. Serum status indicators responded significantly to respective supplementation with vitamins K and D. Over 2 years, serum vitamin K(1) increased by 157% (p < 0.001), the percentage of undercarboxylated osteocalcin (%GluOC) decreased by 51% (p < 0.001), serum 25-hydroxyvitamin D [25(OH)D] increased by 17% (p < 0.001), and PTH decreased by 11% (p = 0.049). CONCLUSIONS: These results provide evidence of a modest synergy in healthy older women from nutritionally relevant intakes of vitamin K(1) together with supplements of calcium plus moderate vitamin D(3) to enhance BMC at the ultradistal radius, a site consisting of principally trabecular bone. The substantial increase in gamma-carboxylation of osteocalcin by vitamin K may have long-term benefits and is potentially achievable by increased dietary intakes of vitamin K rather than by supplementation.
机译:在一项为期两年的双盲安慰剂对照试验中,对健康的老年妇女进行了维生素K(1),维生素D(3)和钙或其组合的膳食补充剂研究。维生素K与维生素D加钙的组合与超远端radius骨的BMC适度但显着增加有关,而与髋部或radius骨的其他部位无关。简介:在一项为期2年的健康苏格兰妇女的双盲,安慰剂对照试验中,研究了高饮食维生素K(1)(叶醌)对BMD的假定有益作用以及与维生素D交互作用的可能性,该试验在健康的苏格兰妇女中进行,为>或= 60岁。材料与方法:健康,非骨质疏松的妇女(n = 244)被随机分配接受(1)安慰剂,(2)200微克/天的维生素K(1),(3)10微克(400 IU)的维生素D(3)。每天添加1000毫克钙,或(4)结合维生素K(1)和D(3)加上钙。基线和6个月的测量包括髋部和腕部的DXA骨矿物质扫描,骨转换的标志物和维生素状态。使用多变量通用线性模型对补充效果进行了测试,并对基线和潜在的混杂变量进行了完全调整。结果:仅在中dist骨半径处观察到明显的骨矿物质流失,而各组之间无显着差异。但是,同时服用维生素K和维生素D加钙的妇女在超dist骨部位的BMD和BMC均持续显着增加。血清状态指标对维生素K和D的补充有显着反应。两年来,血清维生素K(1)增加了157%(p <0.001),羧化骨钙蛋白(%GluOC)的百分比降低了51%(p < 0.001),血清25-羟基维生素D [25(OH)D]增加17%(p <0.001),PTH减少11%(p = 0.049)。结论:这些结果提供了健康老年妇女适度协同作用的证据,这些营养摄入来自与营养有关的维生素K(1)以及钙和中度维生素D(3)的补充,以增强超远端半径的BMC,该部位主要由小梁组成骨。维生素K会使骨钙素的γ羧化作用大量增加可能具有长期益处,并且有可能通过增加饮食中维生素K的摄入量而不是通过补充来实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号